| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963316 | Vaccine | 2016 | 6 Pages |
Abstract
The emerging clinical experience with Bexsero is consistent with findings from pre-licensure clinical studies, and no new safety concerns have been identified. Additional data on length of protection, potential impact on meningococcal carriage and transmission and strain coverage have also been published and will be reviewed.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Philip S. Watson, David P.J. Turner,